COMPARATIVE ANALYSIS OF MATERNAL AND FETAL OUTCOMES IN PCOS AND NON-PCOS WOMEN: A PROSPECTIVE OBSERVATIONAL STUDY
Main Article Content
Keywords
Polycystic ovary syndrome, maternal outcomes, fetal outcomes, Rotterdam 2003 criteria, Neonatal Intensive Care Unit.
Abstract
Background: The purpose of this study is to examine the medical outcomes of women and their unborn children in communities that do not have polycystic ovarian syndrome (PCOS) and communities that do have PCOS. There will be a comparison between the two groups. The comparison will take into consideration a variety of factors, including but not limited to premature delivery, birth weight, hospitalizations to the Neonatal Intensive Care Unit (NICU), and gestational diabetes and hypertension disorders.
Methods: In this prospective longitudinal study, there were a total of 65 women who were either diagnosed with polycystic ovarian syndrome (PCOS) or did not have PCOS. The participants ranged in age from 16 to 45 years old. The length of time that the research was conducted was twenty-four months. A comprehensive investigation was carried out on a number of elements, including demographic data, the difficulties that the mother encountered, the method of delivery, and the outcomes for the infant. A successful acquisition of ethical approval was also accomplished, in addition to the successful acquisition of informed permission from persons.
Results: During pregnancy, women who were diagnosed with polycystic ovarian syndrome (PCOS) had a considerably higher incidence of gestational diabetes, pregnancy-induced hypertension, multifetal pregnancies, early labor, and losses than those who did not have the condition. I would want to bring to your notice the fact that the PCOS group had a higher incidence of preterm deliveries, low birth weight, intrauterine growth restriction, and adverse neonatal outcomes. This is an essential topic to bring to your attention. Among the female participants, those who were diagnosed with polycystic ovarian syndrome (PCOS) had a considerably greater risk of having maternal problems. These difficulties included pregnancy-induced hypertension and gestational diabetes.
Conclusion: According to the findings of this research, polycystic ovarian syndrome (PCOS) has been demonstrated to have a significant impact on the outcomes for both the mother and the fetus being carried by the mother. Women who have polycystic ovarian syndrome (PCOS) are at a greater risk of experiencing catastrophic neonatal outcomes, hypertension, and gestational diabetes. As a result, the importance of individualized therapy is brought into sharper emphasis. Having a complete comprehension of these interrelationships is absolutely necessary for those who suffer from polycystic ovary syndrome (PCOS) to reach the highest possible level of reproductive health.
References
2. Fernandez RC, et al. Diagnosis delayed: health profile differences between women with undiagnosed polycystic ovary syndrome and those with a clinical diagnosis by age 35 years. Hum Reprod. 2021;36:2275–84.
3. Rotterdam ESHRE/ASRM-Sponsored PCOS consensus workshop group. Revised 2003 consensus on diagnostic criteria and long-term health risks related to PCOS. Hum Reprod 2004; 19(1): 41–47.
4. Lim SS, Davies MJ, Norman RJ, Moran LJ. Overweight, obesity and central obesity in women with polycystic ovary syndrome: a systematic review and meta-analysis. Hum Reprod Update. 2012 Nov-Dec;18(6):618-37.
5. Lizneva D, Suturina L, Walker W, Brakta S, Gavrilova-Jordan L, Azziz R. Criteria, prevalence, and phenotypes of polycystic ovary syndrome. Fertil Steril. 2016 Jul;106(1):6-15.
6. Homburg R. Polycystic ovary syndrome. Best Pract Res Clin Obstet Gynaecol 2008; 22(2): 261–274.
7. Nelson VL, Qin KN, Rosenfield RL, et al. The biochemical basis for increased testosterone production in theca cells propagated from patients with polycystic ovary syndrome. J Clin Endocrinol Metab 2001; 86(12): 5925–5933.
8. Doherty DA, Newnham JP, Bower C, et al. Implications of polycystic ovary syndrome for pregnancy and for the health of offspring. Obstet Gynecol 2015; 125(6): 1397–1406.
9. Palomba S, Santagni S, Falbo A, La Sala GB. Complications and challenges associated with polycystic ovary syndrome: current perspectives. Int J Womens Health. 2015;7:745.
10. Haakova L, Cibula D, Rezabek K, Hill M, Fanta M, Zivny J. Pregnancy outcomeinwomen with PCOS and in controls matched by age and weight. Hum Reprod 2003; 18:1438–1441.
11. Shivananjaiah C, KannanA, DeviM, Jayanthi, Satish D, RamaiahR.Polycystic ovarian syndrome and pregnancy outcome.Int J Reprod Contracept Obstet Gynecol2017;6:3804-7.
12. Shringi MS, Vaidya RA, Vaidya AB. Insulin resistance in Polycystic Ovary Syndrome:A study of 90 patients. Indian J Endocrinol Metab. 2003;1:19–23.
13. Surendra, Choudhary V. A prospective control study evaluating pregnancy outcome in PCOS patients: The bottom line truth of modern lifestyle. Int J Surg Sci 2018;2(1):28-32.
14. Lo JC, Feigenbaum SL, Escobar GJ, Yang J,Crites YM, Ferrara A. Increased prevalence of gestational diabetes mellitus among women with diagnosed polycystic ovary syndrome: apopulation based study. DiabCare. 2006;29(8):1915-21.
15. Boomsma CM, Eijkemans MJ, Hughes EG, Visser GH, Fauser BC, Macklon NS. A meta-analysis of pregnancy outcomes in women with polycystic ovary syndrome. Hum Reprod Update 2006;12:673–683.
16. Kjerulff LE, Sanchez-Ramos L, Duffy D. Pregnancy outcomes in women with polycystic ovary syndrome: a meta-analysis. Am J Obstet Gynecol 2011;204:558.e1–558.e–6.
17. Johnston J, Gusmano MK, Patrizio P. Preterm births, multiples, and fertility treatment: recommendations for changes to policy and clinical practices. Fertil Steril 2014; 102:36–39.
18. Rao A, Sairam S, Shehata H. Obstetric complications of twin pregnancies. Best Pract Res Clin Obstet Gynaecol 2004;18:557–576.
19. Okun N, Sierra S; GENETICS COMMITTEE; SPECIAL CONTRIBUTORS. Pregnancy outcomes after assisted human reproduction. J Obstet Gynaecol Can. 2014 Jan;36(1):64-83.
20. Løvvik TS, Wikström AK, Neovius M, Stephansson O, Roos N, Vanky E. Pregnancy and perinatal outcomes in women with polycystic ovary syndrome and twin births: a population-based cohort study. BJOG. 2015 Sep;122(10):1295-302.
21. Joham AE, Boyle JA, Ranasinha S, Zoungas S, Teede HJ. Contraception use and pregnancy outcomes in women with polycystic ovary syndrome: data from the Australian Longitudinal Study on Women's Health. Hum Reprod. 2014 Apr;29(4):802-8.
22. Roos N, Kieler H, Sahlin L, Ekman-Ordeberg G, Falconer H, Stephansson O. Risk of adverse pregnancy outcomes in women with polycystic ovary syndrome: population-based cohort study. Br Med J 2011;343:d6309.
23. Naver KV, Grinsted J, Larsen SO, Hedley PL, Jørgensen FS, Christiansen M, Nilas L. Increased risk of preterm delivery and pre-eclampsia in women with polycystic ovary syndrome and hyperandrogenaemia. BJOG 2014;121:575–581.
24. Han AR, Kim HO, Cha SW, Park CW, Kim JY, Yang KM, Song IO, Koong MK, Kang IS. Adverse pregnancy outcomes with assisted reproductive technology in non-obese women with polycystic ovary syndrome: a case–control study. Clin Exp Reprod Med 2011;38:103–108.
25. Palomba S, Chiossi G, Falbo A, Orio F, Tolino A, Colao A, La Sala GB, Zullo F. Low-grade chronic inflammation in pregnant women with polycystic ovary syndrome. J Clin Endocrinol Metab 2014a;99:2942–2951.
Article Sidebar
Article Details
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
All articles published in JPTCP are licensed under Copyright Creative Commons Attribution-NonCommercial 4.0 International License.
Benudhar Pande
Associate professor Department of O&G, VIMSAR, Burla
Kishore Chandra Mahapatra
Assistant professor Department of O&G VIMSAR, Burla
Kambupani Dash
Post graduate VIMSAR ,Burla Department of Obstetrics and gynaecology
Subhakant Mohanty
Subhakant Mohanty Senior resident VIMSAR,Burla